The implementation of community-based diabetes and hypertension management care program in Indonesia

Levina Chandra Khoe, Grace Wangge, Pradana Soewondo, Dicky L. Tahapary, Indah Suci Widyahening

Research output: Contribution to journalArticle

Abstract

Since 2010, Indonesian government has initiated a chronic disease management program, Prolanis (Program Pengendalian Penyakit Kronis) targeted for diabetes and hypertension. The program is continued at the commencement of universal health coverage (UHC) in 2014. "This study aimed to report the utilization and cost of the implementation of Prolanis in Indonesia from 2014 to 2016, or two years since the commencement of Indonesian universal health coverage." Secondary data analysis was performed using publicly available data and data obtained from the national health insurance agency (BPJS); while data on disease prevalence were collected from basic national health survey. There was an increase trend of Prolanis participants, from around 11,000 participants in 2014 to more than 250,000 in 2016. More than 70% of participants were adults living in Java, however, the acceptance rate was very low in other area. Across different activities in Prolanis, physical activity was the most participated ones. In comparison to other regions, regions in Java were the most active area. The total expenditure for Prolanis program in 2016 increased almost triple from the annual cost in 2014. However, the cost per person was actually decreased more than 50%. Within two years of UHC implementation, there were increase covered participants and total costs, but cost per individual was decreased and there was significant difference in of cost between Java and outside Java. Further study and routine monitoring-evaluation process by health authority is needed to assess whether the cost difference would affect the service quality.

Original languageEnglish
Pages (from-to)e0227806
JournalPloS one
Volume15
Issue number1
DOIs
Publication statusPublished - 1 Jan 2020

Fingerprint

Indonesia
Medical problems
hypertension
diabetes
Hypertension
Costs and Cost Analysis
Universal Coverage
Costs
Health
health insurance
national surveys
disease prevalence
Health insurance
chronic diseases
physical activity
data analysis
disease control
National Health Programs
Disease Management
Health Expenditures

Cite this

@article{454de5e7652241f983cb798c93a87b2b,
title = "The implementation of community-based diabetes and hypertension management care program in Indonesia",
abstract = "Since 2010, Indonesian government has initiated a chronic disease management program, Prolanis (Program Pengendalian Penyakit Kronis) targeted for diabetes and hypertension. The program is continued at the commencement of universal health coverage (UHC) in 2014. {"}This study aimed to report the utilization and cost of the implementation of Prolanis in Indonesia from 2014 to 2016, or two years since the commencement of Indonesian universal health coverage.{"} Secondary data analysis was performed using publicly available data and data obtained from the national health insurance agency (BPJS); while data on disease prevalence were collected from basic national health survey. There was an increase trend of Prolanis participants, from around 11,000 participants in 2014 to more than 250,000 in 2016. More than 70{\%} of participants were adults living in Java, however, the acceptance rate was very low in other area. Across different activities in Prolanis, physical activity was the most participated ones. In comparison to other regions, regions in Java were the most active area. The total expenditure for Prolanis program in 2016 increased almost triple from the annual cost in 2014. However, the cost per person was actually decreased more than 50{\%}. Within two years of UHC implementation, there were increase covered participants and total costs, but cost per individual was decreased and there was significant difference in of cost between Java and outside Java. Further study and routine monitoring-evaluation process by health authority is needed to assess whether the cost difference would affect the service quality.",
author = "Khoe, {Levina Chandra} and Grace Wangge and Pradana Soewondo and Tahapary, {Dicky L.} and Widyahening, {Indah Suci}",
year = "2020",
month = "1",
day = "1",
doi = "10.1371/journal.pone.0227806",
language = "English",
volume = "15",
pages = "e0227806",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "1",

}

The implementation of community-based diabetes and hypertension management care program in Indonesia. / Khoe, Levina Chandra; Wangge, Grace; Soewondo, Pradana; Tahapary, Dicky L.; Widyahening, Indah Suci.

In: PloS one, Vol. 15, No. 1, 01.01.2020, p. e0227806.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The implementation of community-based diabetes and hypertension management care program in Indonesia

AU - Khoe, Levina Chandra

AU - Wangge, Grace

AU - Soewondo, Pradana

AU - Tahapary, Dicky L.

AU - Widyahening, Indah Suci

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Since 2010, Indonesian government has initiated a chronic disease management program, Prolanis (Program Pengendalian Penyakit Kronis) targeted for diabetes and hypertension. The program is continued at the commencement of universal health coverage (UHC) in 2014. "This study aimed to report the utilization and cost of the implementation of Prolanis in Indonesia from 2014 to 2016, or two years since the commencement of Indonesian universal health coverage." Secondary data analysis was performed using publicly available data and data obtained from the national health insurance agency (BPJS); while data on disease prevalence were collected from basic national health survey. There was an increase trend of Prolanis participants, from around 11,000 participants in 2014 to more than 250,000 in 2016. More than 70% of participants were adults living in Java, however, the acceptance rate was very low in other area. Across different activities in Prolanis, physical activity was the most participated ones. In comparison to other regions, regions in Java were the most active area. The total expenditure for Prolanis program in 2016 increased almost triple from the annual cost in 2014. However, the cost per person was actually decreased more than 50%. Within two years of UHC implementation, there were increase covered participants and total costs, but cost per individual was decreased and there was significant difference in of cost between Java and outside Java. Further study and routine monitoring-evaluation process by health authority is needed to assess whether the cost difference would affect the service quality.

AB - Since 2010, Indonesian government has initiated a chronic disease management program, Prolanis (Program Pengendalian Penyakit Kronis) targeted for diabetes and hypertension. The program is continued at the commencement of universal health coverage (UHC) in 2014. "This study aimed to report the utilization and cost of the implementation of Prolanis in Indonesia from 2014 to 2016, or two years since the commencement of Indonesian universal health coverage." Secondary data analysis was performed using publicly available data and data obtained from the national health insurance agency (BPJS); while data on disease prevalence were collected from basic national health survey. There was an increase trend of Prolanis participants, from around 11,000 participants in 2014 to more than 250,000 in 2016. More than 70% of participants were adults living in Java, however, the acceptance rate was very low in other area. Across different activities in Prolanis, physical activity was the most participated ones. In comparison to other regions, regions in Java were the most active area. The total expenditure for Prolanis program in 2016 increased almost triple from the annual cost in 2014. However, the cost per person was actually decreased more than 50%. Within two years of UHC implementation, there were increase covered participants and total costs, but cost per individual was decreased and there was significant difference in of cost between Java and outside Java. Further study and routine monitoring-evaluation process by health authority is needed to assess whether the cost difference would affect the service quality.

UR - http://www.scopus.com/inward/record.url?scp=85077909589&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0227806

DO - 10.1371/journal.pone.0227806

M3 - Article

C2 - 31935256

AN - SCOPUS:85077909589

VL - 15

SP - e0227806

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 1

ER -